Friday, December 03, 2021 10:23:09 AM
All info? Ancient info has been discounted. A term young investors must grasp.
What possible value does the fact that Nader wrote a 100$ check that bounced?
How many readers have had a check bounce? A potential felony??? Thats a joke.
Now travel into my vision. CYDY earns 2$ a share. I predict it trades at 100X earnings. Share value 200$
What value is that 20 year old news in the price of CYDY's common???
ZERO
Move into the future just a month or two. Many events can occur. Funding certainly is no longer a threat. Another important event hits. Wham, CYDY hits 4, 5, or 6$.
In that scene yesterdays news has little value. Next Mondays news a tiny bit more value, and the day before an important even some value.
News 20 years ago? As close to zero value as I have ever experienced.
To write otherwise is misleading current and potential new investors.
I will ask anyone reading this to just considrer the above. It will alter your future.
If you come into CYDY thinking of investing every dime you own, dont do it. Don't bet the farm. Buy many companies with huge growth potential.
What possible value does the fact that Nader wrote a 100$ check that bounced?
How many readers have had a check bounce? A potential felony??? Thats a joke.
Now travel into my vision. CYDY earns 2$ a share. I predict it trades at 100X earnings. Share value 200$
What value is that 20 year old news in the price of CYDY's common???
ZERO
Move into the future just a month or two. Many events can occur. Funding certainly is no longer a threat. Another important event hits. Wham, CYDY hits 4, 5, or 6$.
In that scene yesterdays news has little value. Next Mondays news a tiny bit more value, and the day before an important even some value.
News 20 years ago? As close to zero value as I have ever experienced.
To write otherwise is misleading current and potential new investors.
I will ask anyone reading this to just considrer the above. It will alter your future.
If you come into CYDY thinking of investing every dime you own, dont do it. Don't bet the farm. Buy many companies with huge growth potential.
Recent CYDY News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
- CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer • GlobeNewswire Inc. • 01/27/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/09/2026 10:15:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/09/2026 01:30:45 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/22/2025 10:15:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/17/2025 05:15:14 AM
- December 2025 Letter to Shareholders • GlobeNewswire Inc. • 12/16/2025 01:30:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 12/10/2025 10:16:32 PM
- CytoDyn to Showcase PD-L1 Upregulation and Improved Survival in Metastatic Triple Negative Breast Cancer at the San Antonio Breast Cancer Symposium • GlobeNewswire Inc. • 12/08/2025 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/02/2025 10:15:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:40:20 PM
- CytoDyn Announces Resolution of Class Action Lawsuit • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
